Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma
Philip Schmassmann, Julien Roux, Alicia Buck, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 705
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Dissecting the Ability of Siglecs To Antagonize Fcγ Receptors
Kelli A. McCord, Chao Wang, Mirjam Anhalt, et al.
ACS Central Science (2024) Vol. 10, Iss. 2, pp. 315-330
Open Access | Times Cited: 11
Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2
Ronja Wieboldt, Michael T. Sandholzer, Emanuele Carlini, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 5, pp. 495-509
Open Access | Times Cited: 8
Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma
Yanyan Zheng, Jiawei Wang, Guangya Zhao, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010521-e010521
Open Access
Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec‐9 and Suppresses Macrophage Phagocytosis
Ying Wu, Yuyu You, Ting Jiang, et al.
Advanced Science (2025)
Open Access
CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines
Thomas Look, Roman Sankowski, Manon Bouzereau, et al.
Cell Reports Medicine (2025), pp. 101931-101931
Open Access
Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases
Jannis Wißfeld, Tawfik Abou Assale, Germán Cuevas-Ríos, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 5
Bacterial Biohybrids for Invasion of Tumor Cells Promote Antigen Cross‐Presentation Through Gap Junction
Wen Li, Qi‐Wen Chen, Jin‐Xuan Fan, et al.
Advanced Materials (2024) Vol. 36, Iss. 25
Closed Access | Times Cited: 4
Regulation of sialic acid metabolism in cancer
Filip Filipsky, Heinz Läubli
Carbohydrate Research (2024) Vol. 539, pp. 109123-109123
Open Access | Times Cited: 4
Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade
Liang Zhao, Yizhen Pang, Yangfan Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Brain macrophage senescence in glioma
Lu Li, Tianhe Zhang, Meiling Xiao, et al.
Seminars in Cancer Biology (2024) Vol. 104-105, pp. 46-60
Closed Access | Times Cited: 4
Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation
Shuai Wang, Tengfei Huang, Qiulian Wu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 22
Open Access | Times Cited: 4
The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis
Xin He, Xiantao Zhang, Bolin Wu, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 622-632
Closed Access | Times Cited: 3
Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy
Congwen Wang, Lewei He, Jing Peng, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 8, pp. e009404-e009404
Open Access | Times Cited: 3
Siglec-9+tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer
Yiying Wang, Mengdi He, Chen Zhang, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 9, pp. e007099-e007099
Open Access | Times Cited: 8
MGMT ProFWise: Unlocking a New Application for Combined Feature Selection and the Rank-Based Weighting Method to Link MGMT Methylation Status to Serum Protein Expression in Patients with Glioblastoma
Erdal Taşçı, Yajas Shah, Sarisha Jagasia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4082-4082
Open Access | Times Cited: 2
A Dual Enhancing Strategy of Novel Nanovaccine Based on TIM3 Silencing Nanoadjuvants and Desialylated Cancer Cell Membrane Antigens for Personalized Vaccination Immunotherapy of Cancer
Kaiming Li, Xiaolin Li, Jie Wu, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 2
Sialidase-Chimeric Bioengineered Bacteria for Tumor-Sialoglycan-Triggered Solid Tumor Therapy
Qi‐Wen Chen, Yun Zhang, Peng Bao, et al.
Nano Letters (2024) Vol. 24, Iss. 33, pp. 10362-10371
Closed Access | Times Cited: 2
High expression of SIGLEC7 may promote M2-type macrophage polarization leading to adverse prognosis in glioma patients
Wenhao An, Changyuan Ren, Lei Yuan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Antibody-lectin chimeras for glyco-immune checkpoint blockade
Jessica C. Stark, Melissa A. Gray, Simon Wisnovsky, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Advances in understanding and exploiting Siglec–glycan interactions
Zeinab Jame-Chenarboo, Taylor E. Gray, Matthew S. Macauley
Current Opinion in Chemical Biology (2024) Vol. 80, pp. 102454-102454
Open Access | Times Cited: 1
From mechanism to therapy: the journey of CD24 in cancer
Kai Zhao, Caifeng Wu, Xiangjun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Glycosylation in the tumor immune response: the bitter side of sweetness
Yuting Cao, Wen Yi, Qiang Zhu
Acta Biochimica et Biophysica Sinica (2024) Vol. 56, Iss. 8, pp. 1184-1198
Open Access | Times Cited: 1
Implantable Microneedle‐Mediated Eradication of Postoperative Tumor Foci Mitigates Glioblastoma Relapse
Yulin Zhang, Z Fang, Zejuan Liu, et al.
Advanced Materials (2024)
Open Access | Times Cited: 1
Reshaping the tumor microenvironment by degrading glycoimmune checkpoints Siglec-7 and -9
Chao Wang, Yingqin Hou, Jaroslav Zak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Sialic acid and Siglec receptors in tumor immunity and immunotherapy
Natália Rodrigues Mantuano, Heinz Läubli
Seminars in Immunology (2024) Vol. 74-75, pp. 101893-101893
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top